In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride Drug Master File in Korea (Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride. The MFDS reviews the Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride KDMF as part of the drug registration process and uses the information provided in the Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Eldepryl, L-Deprenyl, Zelapar, Anipryl , Selegiline hydrochloride suppliers with KDMF on PharmaCompass.